Direct Treatment of Mouse or Human Blood With Soluble 5′-Nucleotidase Inhibits Platelet Aggregation
Authors:
- David KöhlerDKDavid Köhler
- Tobias EckleTETobias Eckle
- Doris KloorDKDoris Kloor
- Gregory L. StahlGSGregory L. Stahl
- Holger K. EltzschigHEHolger K. Eltzschig
- 1 August 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (8) , 1477-1483
Abstract
Objective— Adenosine signaling is known to inhibit platelet aggregation. Extracellular adenosine mainly stems from enzymatic phosphohydrolysis of precursor nucleotides via ecto-5′-nucleotidase. Previous studies suggest that soluble 5′-nucleotidase (5′-NT) derived from Crotalus atrox venom may be clinically beneficial in vascular leakage, myocardial, renal, and intestinal ischemia, or acute lung injury. However, the effects of 5′-NT treatment on platelet aggregation remain unknown. We examined the direct effects of 5′-NT treatment on platelet aggregation in vivo and ex vivo using a whole blood aggregation method. Methods and Results— Platelet aggregation in whole human blood was completely inhibited by 5′-NT. When 5′-[αβ-methylene] diphosphate (APCP), a specific 5′-ecto-nucleotidase inhibitor, was added together with 5′-NT, APCP fully restored collagen- or ADP-induced aggregation. Adenosine levels in whole blood were significantly increased after 5′-NT treatment compared to controls and inhibition of platelet aggregation by 5′-NT was completely reversed by pretreatment with the nonspecific adenosine receptor antagonist 8-(p-sulfophenyl)theophylline hydrate (8-SPT), suggesting that 5′-NT inhibits aggregation via increased adenosine signaling. Administration of 5′-NT to mice in vivo abolished ADP- and collagen-induced platelet aggregation and increased adenosine concentrations and tail bleeding time. Conclusions— 5′-NT treatment inhibits platelet aggregation via generation of increased levels of extracellular adenosine and subsequent adenosine receptor signaling.Keywords
This publication has 44 references indexed in Scilit:
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionJournal of Experimental Medicine, 2007
- Physiological Roles of Vascular Nucleoside TransportersArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A 2B Adenosine ReceptorsCirculation, 2007
- ATP Release From Activated Neutrophils Occurs via Connexin 43 and Modulates Adenosine-Dependent Endothelial Cell FunctionCirculation Research, 2006
- Adenosine and Kidney FunctionPhysiological Reviews, 2006
- CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima FormationCirculation, 2006
- Role of CD39 (NTPDase-1) in Thromboregulation, Cerebroprotection, and CardioprotectionSeminars in Thrombosis and Hemostasis, 2005
- Molecular basis for complement component 6 (C6) deficiency in rats and miceImmunobiology, 2004
- Extracellular ATP Metabolism in B and T LymphocytesAnnals of the New York Academy of Sciences, 1990
- 5'-Nucleotidase from smooth muscle of small intestine and from brain. Inhibition by nucleotidesBiochemistry, 1975